These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1689520)

  • 21. Interleukin-15 is the main mediator of lymphocyte proliferation in cultures mixed with human kidney tubular epithelial cells.
    Lewis E; Weiler M; Chaimovitz C; Douvdevani A
    Transplantation; 2001 Sep; 72(5):886-90. PubMed ID: 11571455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of a new immunosuppressive agent, FK506, on human lymphocyte responses in vitro. I. Inhibition of expression of alloantigen-activated suppressor cells, as well as induction of alloreactivity.
    Yoshimura N; Matsui S; Hamashima T; Oka T
    Transplantation; 1989 Feb; 47(2):351-6. PubMed ID: 2465592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergistic effects of sirolimus with cyclosporine and tacrolimus: analysis of immunosuppression on lymphocyte proliferation and activation in rat whole blood.
    Barten MJ; Streit F; Boeger M; Dhein S; Tarnok A; Shipkova M; Armstrong VW; Mohr FW; Oellerich M; Gummert JF
    Transplantation; 2004 Apr; 77(8):1154-62. PubMed ID: 15114077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphocyte-sensitivity to glucocorticoid correlates with the sensitivity to cyclosporin A and tacrolimus in chronic renal failure patients.
    Horigome A; Hirano T; Oka K; Takeuchi H; Sakurai E; Kozaki K; Matsuno N; Nagao T; Kozaki M
    Br J Clin Pharmacol; 1999 Oct; 48(4):573-8. PubMed ID: 10583028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The hydroxylamine of sulfamethoxazole synergizes with FK506 and cyclosporin A, inhibiting T-cell proliferation.
    Hess DA; Bird IA; Almawi WY; Rieder MJ
    J Pharmacol Exp Ther; 1997 Apr; 281(1):540-8. PubMed ID: 9103542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of apoptosis in anti-CD3-treated peripheral blood lymphocytes by immunosuppressive drugs.
    Vathsala A; Chin YM; Noraiza I; Sun L
    Transplant Proc; 2000 Nov; 32(7):1992-4. PubMed ID: 11120034
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of immunosuppressive drugs on functions of activated T lymphocytes. Cyclosporine inhibition of gamma interferon production in the presence of interleukin.
    Bishop GA; Hall BM
    Transplantation; 1988 May; 45(5):967-72. PubMed ID: 3130699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of B cell activation by cyclosporin A, FK506 and rapamycin.
    Wicker LS; Boltz RC; Matt V; Nichols EA; Peterson LB; Sigal NH
    Eur J Immunol; 1990 Oct; 20(10):2277-83. PubMed ID: 1700753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of in vivo responses to cyclosporine, FK506, and rapamycin following allogeneic immune challenge.
    Lorber MI; Wilson JH; Harding MW; Gromkowski S; Marks WH
    Transplantation; 1991 Jul; 52(1):167-70. PubMed ID: 1713364
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of immunosuppressive agents on the induction of nuclear factors that bind to sites on the interleukin 2 promoter.
    Granelli-Piperno A; Nolan P; Inaba K; Steinman RM
    J Exp Med; 1990 Dec; 172(6):1869-72. PubMed ID: 1701825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of cyclosporine and Sirolimus on interleukin-15-driven proliferation of OKT3-preactivated human lymphocytes.
    Degiannis D; Kalteziotis V; Thalassinos A; Kapsalis A; Kroupis C; Koniavitou K
    Transplant Proc; 1998 Jun; 30(4):948-9. PubMed ID: 9636382
    [No Abstract]   [Full Text] [Related]  

  • 32. Mechanism of the combination immunosuppressive effects of rapamycin with either cyclosporine or tacrolimus.
    Khanna AK
    Transplantation; 2000 Aug; 70(4):690-4. PubMed ID: 10972232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A.
    Zeevi A; Duquesnoy R; Eiras G; Rabinowich H; Todo S; Makowka L; Starzl TE
    Transplant Proc; 1987 Oct; 19(5 Suppl 6):40-4. PubMed ID: 2445073
    [No Abstract]   [Full Text] [Related]  

  • 34. The interaction of immunosuppressive compounds in tandem stimulated peripheral human lymphocytes.
    Weaver JL; Pine PS; Aszalos A
    Immunopharmacol Immunotoxicol; 1994 May; 16(2):179-90. PubMed ID: 7521360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FK 506 and deoxyspergualin: additive immunosuppressive effect on rat cardiac allograft rejection in vivo and mitogen-stimulated human lymphocyte responses in vitro.
    Jiang H; Takahara S; Li D; Namiki M; Ishibashi M; Okuyama A; Sonoda T
    Transplant Proc; 1994 Aug; 26(4):2313-6. PubMed ID: 7520631
    [No Abstract]   [Full Text] [Related]  

  • 36. Combined immunosuppressive effect of FK 506 and other immunosuppressive agents on PHA- and CD3-stimulated human lymphocyte proliferation in vitro.
    Jiang H; Suguo H; Takahara S; Takano Y; Li D; Kameoka H; Moutabarrik A; Kokado Y; Ishibashi M; Okuyama A
    Transplant Proc; 1991 Dec; 23(6):2933-6. PubMed ID: 1721317
    [No Abstract]   [Full Text] [Related]  

  • 37. In vitro assessment of triple-therapy immunosuppression and prostaglandin analogues enisoprost and misoprostol.
    Hibbins M; Chapman JR
    Transplant Proc; 1992 Feb; 24(1):224-6. PubMed ID: 1539257
    [No Abstract]   [Full Text] [Related]  

  • 38. Inhibition of T-lymphocyte activation by the immunosuppressive drug FK-506.
    Kay JE; Benzie CR; Goodier MR; Wick CJ; Doe SE
    Immunology; 1989 Aug; 67(4):473-7. PubMed ID: 2475433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of deoxyspergualin on lymphocytes and monocytes in vivo and in vitro.
    Kerr PG; Atkins RC
    Transplantation; 1989 Dec; 48(6):1048-52. PubMed ID: 2531949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gender-related assessment of cyclosporine/prednisolone/sirolimus interactions in three human lymphocyte proliferation assays.
    Ferron GM; Pyszczynski NA; Jusko WJ
    Transplantation; 1998 May; 65(9):1203-9. PubMed ID: 9603169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.